Related Experiment Video
Updated: May 26, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Quantitative myocardial CT perfusion: a pictorial review and the current state of technology development
1Imaging Program, Lawson Health Research Institute, Imaging Research Laboratories, Robarts Research Institute, 100 Perth Drive, London, Ontario, Canada N6A 5K8. aso@imaging.robarts.ca
Insights
Myocardial CT perfusion (CTP) offers a comprehensive assessment for coronary artery disease (CAD). Techniques are improving to overcome limitations like radiation dose and beam hardening, enhancing patient diagnosis and treatment.
Area of Science:
- Cardiovascular Imaging
- Radiology
- Medical Physics
Background:
- Coronary artery disease (CAD) is a major cause of death and healthcare costs.
- Combined anatomic and physiologic assessment can optimize patient selection for revascularization.
- Cardiovascular computed tomography (CT) offers comprehensive CAD evaluation in one session.
Purpose of the Study:
- To review myocardial CT perfusion (CTP) techniques for CAD assessment.
- To discuss methods for overcoming CTP limitations like beam hardening and radiation dose.
- To explore dose reduction and artifact correction strategies for CTP.
Main Methods:
- Review of qualitative, semiquantitative, and quantitative CTP techniques.
- Discussion of beam-hardening correction methods (image-based, dual-energy CT).
- Overview of dose reduction technologies (prospective ECG triggering, iterative reconstruction).
Main Results:
- Beam-hardening correction techniques effectively reduce artifacts.
- Dose reduction technologies show promise for low-dose CTP.
- Quantitative CTP is feasible at reduced radiation doses without compromising accuracy.
Conclusions:
- Myocardial CTP is a valuable tool for comprehensive CAD evaluation.
- Advancements in CTP technology address key limitations, improving clinical utility.
- Further research and validation are ongoing for low-dose, artifact-corrected CTP.
Abstract:
Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality, and is associated with substantial and increasing resource burden. A combined physiologic and anatomic assessment may improve identification of patients with CAD who would benefit from revascularization and reduce unnecessary diagnostic and interventional procedures. Cardiovascular computed tomography (CT) has the potential to provide a comprehensive evaluation of CAD in a single setting. Although coronary CT angiography has been widely implemented for clinical use, the application of myocardial CT perfusion (CTP) has been relatively restricted because of a few limitations, such as beam hardening and the high radiation dose delivered. In this article, we first review the fundamental basis of the qualitative, semiquantitative, and quantitative techniques for myocardial CTP and discussed the strength and weakness of each approach. Beam-hardening correction for myocardial CTP with image-based method and dual-energy CT are then discussed with example cases demonstrating the effectiveness of each method. Initial experiences suggest both techniques can reduce beam-hardening artifact to a satisfactory extent. An overview on dose reduction technologies, such as prospective ECG triggering and iterative reconstruction for myocardial CTP, is also provided. Preclinical studies suggest it is feasible to perform low-dose quantitative myocardial CTP without affecting perfusion measurement. Finally, the impact of scan length on myocardial CTP is addressed.
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

